NCT07122206View on ClinicalTrials.gov

Monitoring the Response of Combination Ursodiol and Seladelpar Treatment

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Primary Biliary Cholangitis
Interventions
PROCEDURE

Blood Draws

Research-related blood draws will be used to ascertain FGF19 levels.

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT07122206 - Monitoring the Response of Combination Ursodiol and Seladelpar Treatment | Biotech Hunter | Biotech Hunter